Paget's disease of bone -often causes pathological fracture,' though Paget made no mention of this complication in his original treatise. Multiple fractures may occur, and some measure of their incidence may be gauged from a series of femoral fractures secondary to Paget's disease described by Barry.-: Thirteen out of 73 patients had two femoral fractures, and four had at intervals sustained three fractures of the same femur. We describe here a particularly florrid case of Paget's disease with multiple fractures, for which calcitonin was prescribed.
Case report
A 73-year-old woman presented with a week's history of a painful right hip and no history of injury. Radiographs showed Paget's disease of the pelvis and femora with a virtually undisplaced transverse fracture of the proximal right femoral shaft. Within the previous two years she had sustained a left subtrochanteric and a right intertrochanteric fracture secondary to Paget's disease. Both had been treated with internal fixation, with a subsequent incisional infection on the right. The underlying metal implant was removed late, after the fracture had united.
The presenting right femoral shaft fracture was initially treated conservatively by immobilisation, but while lifting herself in bed the patient sustained a pathological mid-shaft fracture of the left clavicle. To improve the patient's mobility the femoral fracture was internally fixed with a compression plate, and at surgery the bone was found to be soft and vascular. A spontaneous supracondylar fracture of the same femur occurred soon after operation, this being the third pathological fracture within three weeks. The leg was immobilised in a plaster-of-Paris cylinder. Serum alkaline phosphatase concentration was raised (1750 IU/1), and because of this florrid clinical and biochemical presentation treatment of the Paget's disease was started with salmon calcitonin 100 MRC units daily. The alkaline phosphatase fell dramatically and the subsequent calcitonin dosage was titrated to its fluctuations (see figure) . The serum calcium was normal and after a fall at the onset of treatment remained within the normal range. Seven weeks after the femoral fracture the knee was mobilised, and at 10 weeks the patient started full weight bearing.
No further fractures occurred in the next two years, despite the fact that the patient once had a fall that caused an effusion into the right knee. The calcitonin was discontinued after 10 months of treatment, and since that time two further short courses have been given with benefit for pelvic girdle pain. 
Comment
Calcitonin is advocated in Paget's disease primarily for hypercalcaemia, relief of bone pain)3 and nerve compression.4 There is one other report of calcitonin being used to prevent further pathological fractures, but this was in a 5-year-old boy.5 The beneficial clinical and biochemical responses to calcitonin treatment witnessed in our patient suggest that it may be used to suppress very active Paget's disease with repeated pathological fractures. The rate of union was also favourable, with full weight bearing 10 weeks after the fracture. In a series of 90 femoral fractures in Paget's disease only one out of every five had similar union within three months.2 Rapid union was often associated with abundant callus formation, but in our case little callus was produced with calcitonin treatment. Calcitonin also has the added benefit of preventing bone resorption hypercalcaemia, which is most likely to occur in patients after multiple fractures. 
This technique should be used in accident and emergency departments for turning any unconscious patient with suspected spinal injury. As an ambulance carries only one scoop stretcher, another has to be obtained. In a busy accident department a second ambulance may often be about from which a scoop stretcher could be borrowed. We, however, believe that a second stretcher should be standard equipment in an accident and emergency department. It could then also be used to move the severely injured from trolley to x-ray table or bed. This is much easier and safer, as well as more comfortable for the casualty, than the traditional straight-lift or poles-and-canvas method.
This stretcher has proved popular with the ambulance service and with our general-practitioner accident unit on many occasions.We have found its versatility of great value, even on wet and uneven ground.I We have successfully used it to remove a casualty with spinal injuries lying face down at the bottom of a narrow, 2-m-deep trench and on many occasions at the road-side and on building sites in all weathers.
We thank Mr Polymorphism for the heterochromatic regions of the No 1 chromosomes is common and has no apparent phenotypic effect.' 2 My attention was drawn, however, to a possible association with malignancy by the observation that the normal No 1 chromosomes in the aneuploid tumour cells of two ovarian carcinomas and a seminoma were heteromorphic for their C-band-positive regions. I could not ascertain whether the heteromorphism was present in the patients' normal cells but decided to investigate the incidence of heteromorphism in a series of patients with malignant disease at these and other sites.
Methods and results
Normal cells from 58 patients with malignant disease were studied, either in blood cultures (47 cases) or in direct preparations or cultures of lymphoid or tumour tissue. Seventeen patients had received chemotherapy or radiotherapy. Peripheral blood from 12 normal people and from 36 patients sampled at random from among those referred to the haematology laboratory for blood tests was studied. Cultured lymph nodes from five patients, spleen from one patient, and a fibroblast culture from a normal fetus were also studied. All these control patients had non-malignant conditions. Chromosome preparations made by standard procedures were stained by a C-banding technique.3 Heteromorphism was considered to be present when the areas of the heterochromatic regions of the No 1 chromosomes differed on average by at least 25 % (measurements were made on photographs at a final magnification of x 4500; in most cases, however, the presence or absence of heteromorphism could easily be assessed by direct microscopic observation). All assessments and measurements were made "blind."
Thirty-two of the 58 patients with malignant disease showed the heteromorphism compared with 17 of the 55 controls (see Cytogenetics and Cell Genetics, 1975, 14, 97. 3Sumner, A T, Experimental Cell Research, 1972, 75, 304. 
